Literature DB >> 8826534

Nuclear medicine techniques in the evaluation of pharmaceutical formulations.

A C Perkins1, M Frier.   

Abstract

Nuclear medicine imaging techniques have great potential in the study of the behaviour of drug formulations and drug delivery systems in human subjects. No other technique can locate so precisely the site of disintegration of a tablet in the G1 tract, the depth of penetration of a nebulised solution into the lung, or the residence time of a drug on the cornea. Using the gamma camera to image the in vivo distribution of pharmaceutical formulations radiolabelled with a suitable gamma emitting radionuclide, images may be used to quantify the biodistribution, release and kinetics of drug formulations and delivery from novel carrier systems and devices. Radionuclide tracer techniques allow correlation between the observed pharmacological effects and the precise site of delivery. The strength of the technique lies in the quantitative nature of radionuclide images. Such studies not only provide data on the nature and characteristics of a product, such as reliability and reproducibility but, may also be used in submission to Regulatory Authorities in product registration dossiers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8826534     DOI: 10.1007/bf00417757

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  53 in total

Review 1.  Gamma scintigraphy in the evaluation of pharmaceutical dosage forms.

Authors:  S S Davis; J G Hardy; S P Newman; I R Wilding
Journal:  Eur J Nucl Med       Date:  1992

2.  Comparisons of planar and tomographic gamma scintigraphy to measure the penetration index of inhaled aerosols.

Authors:  P R Phipps; I Gonda; D L Bailey; P Borham; G Bautovich; S D Anderson
Journal:  Am Rev Respir Dis       Date:  1989-06

3.  Deposition pattern from a nasal pump spray.

Authors:  S P Newman; F Morén; S W Clarke
Journal:  Rhinology       Date:  1987-06       Impact factor: 3.681

4.  The in-vivo evaluation of an osmotic device (Osmet) using gamma scintigraphy.

Authors:  S S Davis; J G Hardy; M J Taylor; A Stockwell; D R Whalley; C G Wilson
Journal:  J Pharm Pharmacol       Date:  1984-11       Impact factor: 3.765

5.  The effect of eating on transit through the small intestine.

Authors:  M J Mundy; C G Wilson; J G Hardy
Journal:  Nucl Med Commun       Date:  1989-01       Impact factor: 1.690

6.  The description of the gastrointestinal transit of pellets assessed by gamma scintigraphy using statistical moments.

Authors:  F Podczeck; J M Newton; K H Yuen
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

Review 7.  In vivo evaluation of dosage forms: application of gamma scintigraphy to non-enteral routes of administration.

Authors:  G Meseguer; R Gurny; P Buri
Journal:  J Drug Target       Date:  1994       Impact factor: 5.121

8.  Validity of the geometric mean correction in the quantification of whole bowel transit.

Authors:  J G Hardy; A C Perkins
Journal:  Nucl Med Commun       Date:  1985-04       Impact factor: 1.690

9.  Correlation of ibuprofen bioavailability with gastrointestinal transit by scintigraphic monitoring of 171Er-labeled sustained-release tablets.

Authors:  A F Parr; R M Beihn; R M Franz; G J Szpunar; M Jay
Journal:  Pharm Res       Date:  1987-12       Impact factor: 4.200

10.  Non-invasive detection of gastro-oesophageal reflux using an ambulatory system.

Authors:  N Washington; H A Moss; C Washington; J L Greaves; R J Steele; C G Wilson
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

View more
  2 in total

1.  Magnetic resonance imaging for the in vivo evaluation of gastric-retentive tablets.

Authors:  Andreas Steingoetter; Dominik Weishaupt; Patrick Kunz; Karsten Mäder; Hans Lengsfeld; Miriam Thumshirn; Peter Boesiger; Michael Fried; Werner Schwizer
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

2.  Hydrophilic and lipophilic radiopharmaceuticals as tracers in pharmaceutical development: in vitro--in vivo studies.

Authors:  Mariella Terán; Eduardo Savio; Andrea Paolino; Malcolm Frier
Journal:  BMC Nucl Med       Date:  2005-10-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.